Teva Pharmaceutical Industries (NYSE:TEVA) recently received FDA acceptance of its supplemental Biologics License Application ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we ...

The healthcare sector is tearing in two amid the stock market’s tariff-induced turmoil. Investors looking for safety from ...

Teva Pharmaceutical ( TEVA -1.08%) is my worst-performing stock so far in 2025, down 27% in less than three months as of this ...

Bearish flow noted in Teva (TEVA) with 36,896 puts trading, or 26x expected. Most active are Apr-25 12.5 puts and May-25 16 calls, with total ...

EPYSQLI is designed to treat gMG in adults who are anti-acetylcholine receptor antibody positive.

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

Analysts at Zacks Research raised their FY2025 earnings per share estimates for shares of Teva Pharmaceutical Industries in a ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.